SCHEMBL14396857

SCHEMBL14396857

CN1CCN(CCn2cc(-c3cc(Oc4ccc5nc(NC6CCCCC6)sc5c4)ccn3)cn2)CC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 15/20 0.47
▸ TTK P33981 1/20 0.46
▸ PDGFRB P09619 3/20 0.45
▸ PDGFRA P16234 3/20 0.45
▸ KIT P10721 2/20 0.45
▸ FLT3 P36888 2/20 0.45
▸ MET P08581 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ AXL P30530 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ DYRK2 Q92630 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14396846 0.95 CSF1R (0.49) CSF1RTTKPDGFRBPDGFRAKIT
SCHEMBL14396651 0.93 CSF1R (0.47) CSF1RTTKPDGFRBPDGFRAKIT
SCHEMBL14396851 0.93 CSF1R (0.47) CSF1RTTKPDGFRBPDGFRAKIT
SCHEMBL14396483 0.90 CSF1R (0.51) CSF1RPDGFRBPDGFRAKITFLT3
SCHEMBL2677824 0.90 CSF1R (0.55) CSF1RTTKPDGFRBPDGFRAKIT
SCHEMBL14396825 0.89 CSF1R (0.49) CSF1RPDGFRBPDGFRAKITFLT3
SCHEMBL14396855 0.89 CSF1R (0.49) CSF1RPDGFRBPDGFRAKITFLT3
SCHEMBL14396824 0.88 CSF1R (0.51) CSF1RPDGFRBPDGFRAKITFLT3
SCHEMBL14397057 0.88 CSF1R (0.52) CSF1RPDGFRBPDGFRAKITFLT3
SCHEMBL14396853 0.87 CSF1R (0.44) CSF1RPDGFRBPDGFRAKITFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007121484-A2 6-O-SUBSTITUTED BENZOXAZOLE AND BENZOTHIAZOLE COMPOUNDS AND METHODS OF INHIBITING CSF-1R SIGNALING NOVARTIS AG (CH) 2007-10-25 — — WO disclosed
Send feedback